OCLN and myeloid sarcoma: Moreover, there is experimental evidence that serum from active MS patients reduces the expression of OCLN and VE-cadherin in endothelial cultures suggesting that circulating proinflammatory factors such as cytokines, metalloproteinases as well as reactive oxygen radicals contribute to TJ protein changes and subsequent endothelium alterations12.